AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 41 filers reported holding AC IMMUNE SA in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $718,000 | – | 75,936 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,819,434 | $54,498,000 | 5.95% |
| Prosight Management, LP | 563,900 | $3,130,000 | 1.58% |
| Artal Group S.A. | 1,000,000 | $5,550,000 | 0.22% |
| Temasek Holdings (Private) Ltd | 2,614,095 | $14,508,000 | 0.10% |
| BOOTHBAY FUND MANAGEMENT, LLC | 111,754 | $620,000 | 0.06% |
| COHEN LAWRENCE B | 13,350 | $74,000 | 0.05% |
| Tekla Capital Management LLC | 171,813 | $954,000 | 0.04% |
| Athanor Capital, LP | 42,100 | $234,000 | 0.03% |
| APPLETON PARTNERS INC/MA | 15,360 | $85,000 | 0.01% |
| A.R.T. Advisors, LLC | 30,985 | $172,000 | 0.01% |